You are here: Industry Insights > cancer

News List

Herbal medicine shows potential to treat cancer worldpharmanews
August 09, 2017
Now, three plants used for traditional medicine in Saudi Arabia are shown to be worthy of further investigation for anticancer properties. Cancer is a leading cause of illness and death worldwide.
Gold nanoparticles raise hopes for cancer treatmentsGold nanoparticles raise hopes for cancer treatm europeanpharmaceuticalreview
August 08, 2017
Researchers have discovered properties of the precious metal that allow catalytic abilities to be accessed in living things without any side effects…
Pancreatic cancer patients in England get CDF access to Abraxane pharmatimes
August 07, 2017
Patients with pancreatic cancer living in England can from today potentially get access to a new treatment option after funding for Celgene’s Abraxane was approved for NHS use.
Asia Lung Cancer Summit in Hong Kong, S.A.R., China pharmaasia
August 07, 2017
Oncology experts gather in Hong Kong, S.A.R., China Special Administrative Region of China to share insights and know-how on early cancer diagnosis.
Blood test to detect brain metastases europeanpharmaceuticalreview
August 07, 2017
Cancer researchers are now closer to creating a blood test that can identify breast cancer patients who are at increased risk for developing brain metastasis…
Existing arthritis drug could save thousands in blood cancer treatment pharmafile
August 04, 2017
Findings by researchers at the University of Sheffield have indicated that thousands of pounds could be saved in blood cancer treatment by tapping into the unexplored properties of methotrexate...
BioFluidica pumps $4.1M funding to back its research for cancer diagnosis development biospectrumasia
August 04, 2017
BioFluidica pumps $4.1M funding to back its research for cancer diagnosis development The North Carolina Biotechnology Center awarded BioFluidica a $250,000 Small Business Research Loan in 2015.
Fast-track pancreatic cancer surgery boosts success, saves money pharmatimes
August 03, 2017
Accelerating access to pancreatic surgery has been shown to boost success rates by more than a fifth with a cost saving to the NHS of around £3,200 per patient.
AstraZeneca scores second accelerated FDA review in 2 days for blood cancer drug pharmafile
August 02, 2017
It’s been a rollercoaster week for AstraZeneca. Following the failure of its crucial Mystic trial for its immunotherapy drug Imfinzi, the company has unloaded a string of positive announcements to neutralise potential damage
Breakthrough status for AZ’ lung cancer drug Imfinzi pharmatimes
August 01, 2017
US regulators have granted AstraZeneca’s Imfinzi breakthrough status for the treatment of certain patients with locally-advanced, unresectable non-small cell lung cancer

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page